Controles necesarios en el paciente tratado con azatioprina o mercaptopurina Controls needed in azathioprine or mercaptopurine - treated patients

Controles necesarios en el paciente tratado con azatioprina o mercaptopurina Controls needed in azathioprine or mercaptopurine - treated patients

Bibliographic Details
Main Authors:	R. Pajares Villarroya, N. Manceñido Marcos
Format:	Article
Language:	English
Published:	Aran Ediciones 2009-07-01
Series:	Revista Espanola de Enfermedades Digestivas
Online Access:	http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082009000700010

Similar Items

6-Mercaptopurine Or Azathioprine?
by: McGovern, D, et al.
Published: (2007)

Monitoração terapêutica da azatioprina: uma revisão Therapeutic drug monitoring of azathioprine: a review
by: Maurílio Pacheco Neto, et al.
Published: (2008-06-01)

Hemossiderose pulmonar idiopática tratada com azatioprina: relato de caso em criança Idiopathic pulmonary hemosiderosis treated with azathioprine in a child
by: Clemax Couto Sant`Anna, et al.
Published: (2007-12-01)

Harmful effects of the azathioprine metabolite 6-mercaptopurine in vascular cells: induction of mineralization.
by: Jasmin Prüfer, et al.
Published: (2014-01-01)

Antiviral Potential of Azathioprine and Its Derivative 6- Mercaptopurine: A Narrative Literature Review
by: Carolina Rios-Usuga, et al.
Published: (2024-01-01)

Azathioprine and 6-mercaptopurine-induced intrahepatic cholestasis of pregnancy: Case report and review of the literature
by: Maya Frank Wolf, et al.
Published: (2023-09-01)

Personalised therapy during preconception and gestation in SLE: usefulness of 6-mercaptopurine metabolite levelswith azathioprine
by: Évelyne Vinet, et al.
Published: (2021-10-01)

Azatioprina na doença inflamatória intestinal.
by: Sílvia Leite, et al.
Published: (2009-02-01)

Esquistossomose mansoni experimental: carga parasitária e distribuição de vermes adultos no sistema porta de ratos albinos tratados com Azatioprina
by: Carlos Alberto Moreira Campos
Published: (1983-09-01)

Esquistossomose mansoni experimental: carga parasitária e distribuição de vermes adultos no sistema porta de ratos albinos tratados com Azatioprina
by: Carlos Alberto Moreira Campos
Published: (1983-09-01)

EVOLUÇÃO DO TRANSPLANTE RENAL APÓS SUSPENSÃO DA AZATIOPRINA EM PACIENTES ESTÁVEIS COM IMUNOSSUPRESSÃO TRÍPLICE
by: Euler Pace Lasmar, et al.
Published: (2005-01-01)

Patterns of 6-mercaptopurine and azathioprine maintenance therapy among a cohort of commercially insured individuals diagnosed with Crohn's disease in the United States
by: Lund JL, et al.
Published: (2013-12-01)

Preemptive <i>TPMT</i> Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for Autoimmune Diseases
by: Sarahí Valdez-Acosta, et al.
Published: (2023-07-01)

Evolución clínica en neuromielitis óptica comparando el manejo con azatioprina o rituximab
by: Paulina Sánchez Botero, et al.
Published: (2023-04-01)

AZATIOPRINA COMO TERAPIA DE SEGUNDA LINHA PARA PACIENTES ADULTOS COM TROMBOCITOPENIA IMUNE: EXPERIÊNCIA DE UM HOSPITAL PÚBLICO BRASILEIRO
by: FM Marques, et al.
Published: (2023-10-01)

Azathioprine and Steroids
by: Knight, SR, et al.
Published: (2008)

Azathioprine in ulcerative colitis: final report on controlled therapeutic trial.
by: Jewell, D, et al.
Published: (1974)

Pure erythroid leukemia in a polymyositis patient treated with azathioprine
by: Osamu Imataki, et al.
Published: (2018-05-01)

CYCLOPHOSPHAMIDE, AZATHIOPRINE, AND MALIGNANCY
by: Kinlen, L
Published: (1977)

Azathioprine in ulcerative colitis.
by: Jewell, D, et al.
Published: (1972)

Azathioprine, cyclophosphamide and chlorambucil.
by: Luqmani, R, et al.
Published: (1990)

Design and development of hydrogel nanoparticles for mercaptopurine
by: V Senthil, et al.
Published: (2010-01-01)

Azathioprine Hypersensitivity Syndrome: Two Cases of Febrile Neutrophilic Dermatosis Induced by Azathioprine
by: Majed Aleissa, et al.
Published: (2017-01-01)

Cytotoxicity effect of 6-mercaptopurine and 6-mercaptopurine riboside on RAW 264.7 and HIG-82 cell lines
by: Che Ku Daud, Che Ku Dahlan, et al.
Published: (2014)

Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial.
by: Jewell, D, et al.
Published: (1972)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
by: Tong Li, et al.
Published: (2020-11-01)

Mercaptopurine and inflammatory bowel disease: the other thiopurine
by: Fernando Bermejo, et al.

Effects of 6– Mercaptopurine on Salivary Glands in Rabbit
by: Alhan D Al–Moula, et al.
Published: (2012-08-01)

Mesoporous Silica Modified with Polydopamine and Zinc Ions as a Potential Carrier in the Controlled Release of Mercaptopurine
by: Mariusz Sandomierski, et al.
Published: (2023-06-01)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
by: Elsone, L, et al.
Published: (2012)

Risks and benefits of azathioprine therapy.
by: McGovern, D, et al.
Published: (2005)

Infliximab and azathioprine: bridge or parachute?
by: Travis, S
Published: (2006)

Azathioprine: its uses in dermatology,
by: Sonia Chavez-Alvarez, et al.
Published: (2020-11-01)

Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial
by: Marianne Kiszka-Kanowitz, et al.
Published: (2022-03-01)

AZALEP a randomized controlled trial of azathioprine to treat leprosy nerve damage and Type 1 reactions in India: Main findings.
by: Diana N J Lockwood, et al.
Published: (2017-03-01)

Thiopurine S-Methyltransferase Polymorphisms Predict Hepatotoxicity in Azathioprine-Treated Patients with Autoimmune Diseases
by: Heh-Shiang Sheu, et al.
Published: (2022-08-01)

Un Kant contemporáneo y necesario
by: Marcos Travaglia
Published: (2021-06-01)

Liquen plano con afectación esofágica
by: R. Honrubia-López, et al.
Published: (2020-01-01)

Tratamiento exitoso con azatioprina en un varón con enfermedad relacionada con IgG4. Reporte de caso
by: Freddy Liñán-Ponce, et al.
Published: (2022-11-01)

Elementos necesarios al consentimiento informado en pacientes con esquizofrenia
by: Sergio Ramos Pozón